It is unlikely that you would announce this is ...... (Extract from This mornings orphan Drug status announcement)
The encouraging efficacy data from PYC’s single dose studies in patients
with RP11 is set to be complemented by additional data from two
concurrent multiple dose studies in Q4 2024
To then follow that 35 minutes later with a trading halt that is the bearer of bad news re the trials. But you never never know
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.050(4.17%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.15 | $102.6K | 87.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 66203 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7768 | 6 |
View Market Depth
| Last trade - 13.56pm 18/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |